Register for real-time alerts, custom portfolio, and market movers

Get Started

KALA

KALA BIO (KALA)

KALA BIO Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:KALA

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 Next >>

Date	Time	Source	Headline	Symbol	Company
07/11/2022	8:00AM	GlobeNewswire Inc.	Kala Pharmaceuticals Completes Sale of EYSUVIS® and INVELTYS® to Alcon Inc	NASDAQ:KALA	KALA BIO Inc
07/08/2022	5:02PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:KALA	KALA BIO Inc
06/21/2022	4:16PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:KALA	KALA BIO Inc
06/17/2022	4:46PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KALA	KALA BIO Inc
06/17/2022	4:46PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KALA	KALA BIO Inc
06/17/2022	4:46PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KALA	KALA BIO Inc
06/17/2022	4:46PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KALA	KALA BIO Inc
06/17/2022	4:46PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KALA	KALA BIO Inc
06/17/2022	4:01PM	GlobeNewswire Inc.	Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:KALA	KALA BIO Inc
06/03/2022	5:12PM	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:KALA	KALA BIO Inc
06/02/2022	8:00AM	GlobeNewswire Inc.	Kala Pharmaceuticals to Present at Jefferies Healthcare Conference	NASDAQ:KALA	KALA BIO Inc
06/01/2022	6:00AM	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:KALA	KALA BIO Inc
05/26/2022	5:12PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KALA	KALA BIO Inc
05/24/2022	8:16AM	TipRanks	H.C. Wainwright Sticks to Their Buy Rating for Kala Pharmaceuticals (KALA)	NASDAQ:KALA	KALA BIO Inc
05/23/2022	2:25PM	TipRanks	Wedbush Thinks Kala Pharmaceuticals’ Stock is Going to Recover	NASDAQ:KALA	KALA BIO Inc
05/23/2022	6:05AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:KALA	KALA BIO Inc
05/23/2022	12:01AM	GlobeNewswire Inc.	Kala Announces Entry into Definitive Agreement to Sell EYSUVIS® and INVELTYS® to Alcon Inc.	NASDAQ:KALA	KALA BIO Inc
05/17/2022	6:35AM	TipRanks	Wedbush Sticks to Their Buy Rating for Kala Pharmaceuticals (KALA)	NASDAQ:KALA	KALA BIO Inc
05/16/2022	4:38PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:KALA	KALA BIO Inc
05/16/2022	7:07AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:KALA	KALA BIO Inc
05/16/2022	7:00AM	GlobeNewswire Inc.	Kala Reports First Quarter 2022 Financial Results and Provides Corporate Update	NASDAQ:KALA	KALA BIO Inc
05/09/2022	8:00AM	GlobeNewswire Inc.	Kala Pharmaceuticals to Report First Quarter 2022 Financial Results and Host Conference Call	NASDAQ:KALA	KALA BIO Inc
05/03/2022	8:00AM	GlobeNewswire Inc.	Kala Pharmaceuticals Announces New Commercial and Medicare Coverage for EYSUVIS®	NASDAQ:KALA	KALA BIO Inc
05/01/2022	9:00AM	GlobeNewswire Inc.	Kala Pharmaceuticals to Present Clinical Data for KPI-012, its Mesenchymal Stem Cell Secretome Product, for the Treatment of PCED at the 2022 ARVO Annual Meeting	NASDAQ:KALA	KALA BIO Inc
04/29/2022	4:18PM	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:KALA	KALA BIO Inc
04/29/2022	4:03PM	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:KALA	KALA BIO Inc
04/04/2022	4:01PM	GlobeNewswire Inc.	Kala Pharmaceuticals to Present Phase 1b Clinical Data for KPI-012 in Patients with PCED at 2022 ARVO Annual Meeting	NASDAQ:KALA	KALA BIO Inc
04/01/2022	4:32PM	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:KALA	KALA BIO Inc
03/29/2022	4:42PM	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:KALA	KALA BIO Inc
03/29/2022	7:00AM	GlobeNewswire Inc.	Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update	NASDAQ:KALA	KALA BIO Inc

Showing the most relevant articles for your search:NASDAQ:KALA

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 Next >>

Seafarer Exploration (PK)

Therapeutic Solutions (PK)

Bell Buckle (PK)

NioCorp Developments

Fannie Mae (QB)

Marketing Worldwide (PK)

Good Vibrations Shoes (PK)

Trump Media and Technology

Anavex Life Sciences

Seven Arts Entertainment (PK)

Kraig Biocraft Laborator... (QB)

Brookmount Explorations (PK)

Delayed Upgrade Clock